Kefloridina Forte (Cefalexin)

Cefalexin interferes with bacterial cell wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, weakening the wall and causing bacterial lysis, especially in actively dividing cells.

The dose of Kefloridina Forte is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and renal function. No fixed regimen is provided here; the prescriber sets the appropriate dosage.

Safety data for cefalexin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Kefloridina Forte, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both cefalexin and amoxicillin are beta‑lactam antibiotics, but cefalexin belongs to the cephalosporin class and generally offers broader activity against certain Gram‑positive organisms and some Gram‑negative strains. Amoxicillin may be preferred for infections where beta‑lactamase stability is required, while cefalexin is often chosen for skin, bone and urinary infections.

Kefloridina Forte should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.

Kefloridina Forte is administered orally, typically as tablets or capsules, and should be taken with or without food as directed by the prescriber. The full course should be completed even if symptoms improve, to ensure eradication of the infection.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, significant liver injury, and acute kidney injury in susceptible individuals. Patients should seek immediate medical attention if they experience rash, fever, persistent diarrhea, jaundice, or signs of an allergic response.

Individuals with a known hypersensitivity to cefalexin, other cephalosporins, or penicillins should avoid Kefloridina Forte. It is also contraindicated in patients with a history of severe allergic reactions to beta‑lactam antibiotics and should be used with caution in those with significant renal or hepatic impairment.